Announcements Trials
Browse Landscape

Status

Recruiting 4Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Observational 6

Sponsor

Cancer Type

Tumor-Agnostic 6

Conditions

Neoplasms 6Pancreatic Neoplasms 3Pancreatic Cyst 2Wilms Tumor 1Uveal Melanoma 1Thyroid Nodule 1Thyroid Diseases 1Prostatic Neoplasms 1Peutz-Jeghers Syndrome 1Pancreatitis, Chronic 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Myasthenia Gravis 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Leukemia 1Intestinal Neuroendocrine Tumor 1Hyperthyroidism 1Hip Fractures 1Hematologic Neoplasms 1Goiter 1Glioma 1Glioblastoma 1Frailty 1Fractures, Spontaneous 1Financial Stress 1

Interventions

pembrolizumab 90Blood Specimen Collection 44Cyclophosphamide 37Nivolumab 35Bevacizumab 35Standard of Care 32Carboplatin 30Surveys and Questionnaires 29Paclitaxel 28atezolizumab 24Pemetrexed 24Gemcitabine 24Exercise 24Fluorouracil 23Cisplatin 23Leucovorin 21Dexamethasone 20Radiotherapy 19Oxaliplatin 19Docetaxel 19Rituximab 16Irinotecan 16Cetuximab 16dostarlimab 15Ipilimumab 15Doxorubicin 15Biopsy 15130-nm albumin-bound paclitaxel 15Drug Therapy 14fludarabine 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Neoplasms × Data Collection × 1 year × Clear all
NCT05427136 2026-05-08

SWISS-Pearl

University Children's Hospital Basel

Recruiting
140 enrolled
Tumor-Agnostic

Neoplasms

NCT00684580 2026-04-29

Protocol For Collecting Data On Patients With Childhood Cancer

St. Jude Children's Research Hospital

Recruiting
30,000 enrolled
Tumor-Agnostic

Neoplasms

NCT04477681 2026-03-31

SACHA

Gustave Roussy, Cancer Campus, Grand Paris

Recruiting
1,150 enrolled
Tumor-Agnostic

Neoplasms

NCT06270602 2025-12-22

The ONCOCAMP Study

National Cancer Institute, Naples

Recruiting
15,000 enrolled
Tumor-Agnostic

Neoplasms

NCT07213427 2025-10-08

UNICURE-HD

Assistance Publique - Hôpitaux de Paris

Not yet recruiting
363 enrolled
Tumor-Agnostic

Neoplasms

NCT02159742 2025-07-02

Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases

Abramson Cancer Center at Penn Medicine

Active not recruiting
400 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡